Navigation Links
Statement: Congress Should Include the Physician Self-Referral Provision in the Farm Bill for Patients and Communities
Date:4/18/2008

f-referral would protect patient access to vital health care services, as well as ensure fair competition in health care. That's why Congress must act on their commitment and end the practice of self-referral.

Editor's note: For a listing of research addressing self-referral, contact Elizabeth Lietz at (202) 626-2284.


'/>"/>
SOURCE American Hospital Association; Federation of AmericanHospitals;
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
2. TriWest Sponsors Congressional Medal of Honor Convention
3. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
4. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
5. EDAP Launches Enhanced Communication Plans at SIU Paris Congress
6. World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress
7. Congress Poised to Add Millions of Uninsured Children to Successful, Bipartisan Health Plan
8. National Council on Disability Urges Congress to Support Americans with Disabilities Act Restoration
9. MUHC in the spotlight at the 14th World Congress on In Vitro Fertilization
10. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
11. Health IT Now! Coalition Urges Congress to Pass Health Information Technology Bill This Year
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 1Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 2Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 3BioCryst to Present at UBS Global Life Sciences Conference 57575 1BioCryst to Present at UBS Global Life Sciences Conference 57575 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 1Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 3Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 4Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 5Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 6Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 7Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 8Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 9Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 10Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 11Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 12Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 13Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 14Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 15